BeStock  
Stocks › Biotechnology › DFTX

Definium Therapeutics DFTX

US equityMarket cap rank #2233Biotechnology
$28.34 −$1.14 (-3.87%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.05 -1.02%
Open$29.14
Prev close$29.48
Day range$28.18 – $29.51
Volume3.24M
Market cap$3.88B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-11.0x
CheapRich

Near the bottom of its 5-year range · 9th percentile, 5-year average -4.2x

Price / book4.5x
CheapRich

Above its usual level · 70th percentile, 5-year average 4.0x

#4283 of 5331 stocks by PB (1 = cheapest)

P/E over five years

-22x-14x-6x2xOct '21Aug '23Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$37.00
Price vs. fair value-23.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.54 – 3.99 70% (pricier than usual) #4283 of 5331 (1 = cheapest)
PE -10.99 -15.79 -4.24 9% (cheaper than usual) –
PS – 276.67 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on DFTX.

Sign in to join the discussion.

Scroll to Top